Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 3 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Results 1 - 20 of 33 : 1 2 Next »

Recs

0
Member Avatar marsuculix (< 20) Submitted: 7/9/2014 5:34:40 AM : Outperform Start Price: $3.36 AGEN Score: -2.58

Breaking News: Agenus brain cancer vaccine boosts survival in PhII trial !

Recs

1
Member Avatar s2dbaker (89.70) Submitted: 10/14/2013 10:39:17 PM : Outperform Start Price: $2.76 AGEN Score: +3.33

Sparks of hope in revenue numbers make this a purely speculative choice. Here's to rolling the dice.

Recs

1
Member Avatar zzlangerhans (99.75) Submitted: 4/3/2013 1:23:04 AM : Outperform Start Price: $3.94 AGEN Score: -42.15

I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to raise ahead of data. If they do, expect disappointment ahead.

Recs

2
Member Avatar TMFSarahGen (99.73) Submitted: 8/17/2011 12:13:24 PM : Outperform Start Price: $3.42 AGEN Score: -68.92

they just raised money at 51cents, so that should be a floor for a little while.

Recs

0
Member Avatar ExploitTopFools (96.17) Submitted: 8/1/2010 10:08:46 PM : Outperform Start Price: $5.40 AGEN Score: -115.12

next round of speculative outperformers. very risky (except for the few at the end of the list).

tickers: gkk,anpi,tstr,agen,htm,ddss,vtg,erii,swhc,brnc,chk,bgp,bks,hlcs,cog,jec,gy

Recs

0
Member Avatar nickolassc (< 20) Submitted: 6/24/2010 12:34:26 PM : Outperform Start Price: $5.33 AGEN Score: -121.13

I've been following this company for a while. I feel it's a buy under .90 cents, the vaccine technology in QS-21 and some of their other treatments are the future of vaccines and fighting cancer, and they have the real deal. This company will make Dendreon look small if it can hang on through the clinical trials and doesn't get bought out.

Recs

0
Member Avatar beachjim37 (< 20) Submitted: 10/12/2009 6:46:36 AM : Outperform Start Price: $12.66 AGEN Score: -156.86

Great news in next 90 days likely

Recs

0
Member Avatar flatky02 (< 20) Submitted: 10/5/2009 6:50:10 AM : Outperform Start Price: $12.24 AGEN Score: -165.09

This BioPharm is getting hot. I'd say that this company and CVM are nippin at the heals of large sector growth. We should see a double in stock price within a year... but probably more. Give it a few years... and this is a potential billion dollar company in the $20 stock range. Great price to buy!

Recs

0
Member Avatar libertybrewcity (< 20) Submitted: 9/10/2009 10:24:31 PM : Outperform Start Price: $14.58 AGEN Score: -165.99

seems like a decent stock. only about a million in sales per quarter and a fairly substantial amount of long term debt, but there is promise for both drugs in phase 2.

Recs

0
Member Avatar Brian7992 (58.42) Submitted: 8/11/2009 2:29:09 PM : Outperform Start Price: $12.42 AGEN Score: -171.61

How Should I know!

Recs

0
Member Avatar number90 (< 20) Submitted: 8/4/2009 10:19:21 PM : Outperform Start Price: $13.92 AGEN Score: -172.82

Time to buy.... stock has finished consolidating... recent upward change to private placement price, plus recent move in stock price confirms big money wants in... should see a nice run as summer ends and we get closer to EMEA decision

Recs

0
Member Avatar poconobear (98.02) Submitted: 7/25/2009 7:48:51 AM : Outperform Start Price: $13.80 AGEN Score: -178.39

biotech spec

Recs

0
Member Avatar svande8952 (< 20) Submitted: 6/16/2009 11:09:34 AM : Underperform Start Price: $12.24 AGEN Score: +187.93

recent run up looks prime for thumbs down

Recs

0
Member Avatar sbream (< 20) Submitted: 7/1/2008 9:23:03 PM : Outperform Start Price: $11.40 AGEN Score: -128.85

Hopefully FDA approves the export...

Recs

0
Member Avatar Dart65GTConv (< 20) Submitted: 6/24/2008 9:45:00 AM : Outperform Start Price: $10.62 AGEN Score: -124.56

u[p

Recs

0
Member Avatar 4reverse4 (< 20) Submitted: 5/12/2008 1:25:22 AM : Outperform Start Price: $13.86 AGEN Score: -123.01

Chart is looking up! Buying and then selling in a couple weeks when I feel it's peaked

Recs

0
Member Avatar nolaig90 (< 20) Submitted: 5/9/2008 7:10:48 AM : Outperform Start Price: $13.98 AGEN Score: -124.11

once sales of this product hit the market and there proven benifits to the vacine i can see this stock grow expotentially.

Recs

0
Member Avatar Marauder03 (< 20) Submitted: 4/25/2008 11:51:52 AM : Outperform Start Price: $13.37 AGEN Score: -122.92

Who wouldn't want a vaccine to save their life?

Recs

0
Member Avatar antigrowth (99.12) Submitted: 4/10/2008 2:17:16 AM : Outperform Start Price: $16.62 AGEN Score: -131.12

Will pop up because of the russian approval.

Recs

0
Member Avatar cooker0stp (< 20) Submitted: 4/9/2008 8:53:20 PM : Outperform Start Price: $16.62 AGEN Score: -131.12

Russia will become haven for terminal cancer patients.

Results 1 - 20 of 33 : 1 2 Next »

Featured Broker Partners


Advertisement